Poly Medicure Limited
Healthcare›Healthcare›Healthcare Equipment & Supplies›Medical Equipment & Supplies
Key metrics
Price as of 2026-07-17
Stock price
₹1680.50
Market cap
17,033 Cr
Stock P/E
57.1
P/B
5.41
Dividend yield
0.2%
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 321 Cr | 658 Cr | 998 Cr | 1,376 Cr | 385 Cr | 805 Cr | 424 Cr | 441 Cr | 403 Cr | 444 Cr | 494 Cr | 535 Cr |
| Operating expenses (approx.) | 220 Cr | 459 Cr | 692 Cr | 959 Cr | 264 Cr | 543 Cr | 288 Cr | 297 Cr | 255 Cr | 295 Cr | 363 Cr | 406 Cr |
| EBITDA | 101 Cr | 199 Cr | 305 Cr | 417 Cr | 121 Cr | 262 Cr | 136 Cr | 144 Cr | 148 Cr | 149 Cr | 131 Cr | 128 Cr |
| OPM % | 31.5% | 30.2% | 30.6% | 30.3% | 31.4% | 32.6% | 32.1% | 32.6% | 36.7% | 33.5% | 26.5% | 24.0% |
| Other income | 13 Cr | 27 Cr | 44 Cr | 59 Cr | 17 Cr | 43 Cr | 22 Cr | 24 Cr | 42 Cr | 34 Cr | 26 Cr | 18 Cr |
| Interest | 2 Cr | 5 Cr | 8 Cr | 11 Cr | 3 Cr | 7 Cr | 3 Cr | 2 Cr | 3 Cr | 3 Cr | 6 Cr | 6 Cr |
| Depreciation | 16 Cr | 32 Cr | 48 Cr | 64 Cr | 20 Cr | 41 Cr | 22 Cr | 21 Cr | 23 Cr | 25 Cr | 29 Cr | 38 Cr |
| Profit before tax | 83 Cr | 162 Cr | 250 Cr | 342 Cr | 98 Cr | 215 Cr | 112 Cr | 121 Cr | 122 Cr | 121 Cr | 96 Cr | 84 Cr |
| Tax % | 24.5% | 24.1% | 24.8% | 25.2% | 24.9% | 25.5% | 25.1% | 25.7% | 24.6% | 24.8% | 27.9% | 24.2% |
| Net profit | 63 Cr | 125 Cr | 190 Cr | 258 Cr | 74 Cr | 161 Cr | 85 Cr | 92 Cr | 93 Cr | 92 Cr | 71 Cr | 65 Cr |
| EPS (₹) | ₹6.54 | ₹13.02 | ₹19.79 | ₹26.92 | ₹7.71 | ₹16.73 | ₹8.48 | ₹8.92 | ₹9.19 | ₹9.06 | ₹7.00 | ₹6.54 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2019 | Mar 2020Standalone only | Mar 2021Standalone only | Mar 2022Standalone only | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 611 Cr | 687 Cr | 786 Cr | 923 Cr | 1,115 Cr | 1,376 Cr | 1,670 Cr | 1,875 Cr | Sign in for TTM |
| Operating expenses (approx.) | 462 Cr | 505 Cr | 554 Cr | 672 Cr | 850 Cr | 1,018 Cr | 1,128 Cr | 1,320 Cr | Sign in for TTM |
| EBITDA | 149 Cr | 182 Cr | 233 Cr | 251 Cr | 265 Cr | 358 Cr | 542 Cr | 556 Cr | Sign in for TTM |
| OPM % | 24.4% | 26.5% | 29.6% | 27.2% | 23.8% | 26.0% | 32.5% | 29.6% | Sign in for TTM |
| Other income | 18 Cr | 18 Cr | 18 Cr | 38 Cr | 36 Cr | 59 Cr | 89 Cr | 120 Cr | Sign in for TTM |
| Interest | 12 Cr | 18 Cr | 9 Cr | 4 Cr | 9 Cr | 11 Cr | 12 Cr | 18 Cr | Sign in for TTM |
| Depreciation | 37 Cr | 41 Cr | 48 Cr | 54 Cr | 57 Cr | 64 Cr | 83 Cr | 116 Cr | Sign in for TTM |
| Profit before tax | 100 Cr | 124 Cr | 177 Cr | 193 Cr | 236 Cr | 342 Cr | 447 Cr | 422 Cr | Sign in for TTM |
| Tax % | 34.6% | 24.2% | 25.0% | 25.3% | 24.7% | 25.2% | 25.5% | 25.3% | Sign in for TTM |
| Net profit | 65 Cr | 96 Cr | 136 Cr | 147 Cr | 179 Cr | 258 Cr | 339 Cr | 321 Cr | Sign in for TTM |
| EPS (₹) | ₹7.41 | ₹10.86 | ₹15.25 | ₹15.28 | ₹18.69 | ₹26.92 | ₹34.13 | ₹31.79 | Sign in for TTM |
| Dividend payout % | — | — | — | 16.3% | 13.4% | 11.1% | 9.0% | 11.0% | Sign in for TTM |
Sign in for TTM
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2019 | Mar 2020Standalone only | Mar 2021Standalone only | Mar 2022Standalone only | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 44 Cr | 44 Cr | 48 Cr | 48 Cr | 48 Cr | 48 Cr | 51 Cr | 51 Cr |
| Reserves | 0.0000 Cr | 0.0000 Cr | 0.0000 Cr | 1,040 Cr | 1,194 Cr | 1,422 Cr | 2,715 Cr | 3,055 Cr |
| Borrowings | — | 155 Cr | 91 Cr | 109 Cr | 146 Cr | 170 Cr | 178 Cr | 290 Cr |
| Other liabilities | — | 156 Cr | 143 Cr | 148 Cr | 189 Cr | 218 Cr | 249 Cr | 480 Cr |
| Total liabilities | — | 740 Cr | 1,187 Cr | 1,334 Cr | 1,577 Cr | 1,859 Cr | 3,192 Cr | 3,919 Cr |
| Fixed assets (net) | — | 307 Cr | 367 Cr | 432 Cr | 587 Cr | 819 Cr | 1,038 Cr | 1,255 Cr |
| CWIP | — | 17 Cr | 15 Cr | 37 Cr | 73 Cr | 67 Cr | 90 Cr | 91 Cr |
| Investments | — | 18 Cr | 345 Cr | 337 Cr | 119 Cr | 160 Cr | 1,064 Cr | 740 Cr |
| Other assets | — | 293 Cr | 676 Cr | 741 Cr | 807 Cr | 842 Cr | 1,917 Cr | 1,942 Cr |
| Total assets | — | 740 Cr | 1,187 Cr | 1,334 Cr | 1,577 Cr | 1,859 Cr | 3,192 Cr | 3,919 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2019 | Mar 2020Standalone only | Mar 2021Standalone only | Mar 2022Standalone only | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | — | — | — | 123 Cr | 191 Cr | 266 Cr | 241 Cr | 241 Cr |
| Cash from investing | — | — | — | -85 Cr | -179 Cr | -241 Cr | -1,191 Cr | -225 Cr |
| Cash from financing | — | — | — | -35 Cr | -13 Cr | -20 Cr | 953 Cr | 20 Cr |
| Net cash flow | — | — | — | 3 Cr | -0.69 Cr | 5 Cr | 3 Cr | 35 Cr |
| Free cash flow (OCF − Capex) | — | — | — | -32 Cr | -48 Cr | -11 Cr | -84 Cr | -68 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2019 | Mar 2020Standalone only | Mar 2021Standalone only | Mar 2022Standalone only | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| ROCE % | 253.5% | 321.6% | 386.4% | 18.1% | 15.0% | 17.9% | 15.6% | 12.8% |
| ROE % | 0.0% | 0.0% | 0.0% | 13.5% | 14.4% | 17.6% | 12.2% | 10.2% |
| Debtor days | — | 68 | 73 | 79 | 77 | 72 | — | — |
| Inventory days | — | 178 | 162 | 165 | 179 | 174 | 182 | 263 |
| Days payable | — | 107 | 83 | 86 | 79 | 75 | — | — |
| Cash conversion cycle | — | 139 | 152 | 159 | 177 | 170 | 182 | 263 |
| Debt / equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.12 | 0.12 | 0.06 | 0.09 |
| Current ratio | — | 1.66 | 4.44 | 3.65 | 2.75 | 2.40 | 5.18 | 3.37 |
| Net debt / EBITDA | 0.00 | 0.00 | 0.00 | 0.00 | 0.53 | 0.44 | 0.31 | 0.43 |
Compare with peers
Loading peers…